BPIQ Blog

Jan 4, 20235 min read

How does Lecanemab compare to other Alzheimer's assets?

Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...

Jul 25, 20221 min read

(Posted 10:15am CST) $XBI $80 | -0.84% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Jul 25, 20221 min read

(Posted 10:15am CST) $XBI $80 | -0.84% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Jul 5, 20222 min read

As we reached the end of June last week, we review moves from smid-cap biopharma companies during the month of June. See Table 1 for...

Jun 24, 20223 min read

As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...

Jun 22, 20222 min read

$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...

Jun 22, 20222 min read

$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...

Our platform helps you uncover your next biotech investment opportunity